Simon Hegele Healthcare Solutions Accelerates Global Growth Through Partnership with Brazil’s MR In Site

Simon Hegele Healthcare Solutions, a highly specialized service partner for original equipment manufacturers (OEMs) of large-scale medical equipment, announces a new partnership through a majority shareholder investment, in MR In Site, one of Brazil’s largest manufacturers of RF shielding and installation services provider of medical imaging equipment. The agreement includes affiliates Brazil Riggers and Columbia Riggers, which specialize in the rigging and assembly of linear accelerator systems. Corresponding (preliminary) contracts have been concluded, closing will take place in the first half of 2023.

Located in São Paulo, MR In Site has deep experience in the electromedical equipment industry and earned a reputation for delivering exceptional service since their founding in 2005.

This partnership builds on Simon Hegele’s existing operations in Latin America and supports the ongoing global expansion of the company.

“Our partnership with MR In Site is a great opportunity to expand our capabilities in the South American market,” says Jim Nestel, CEO of the Americas and Asia Pacific for Simon Hegele Healthcare Solutions. “Not only does this alliance increase Simon Hegele’s capacity in Brazil, it rapidly enhances the variety of services we can bring to our combined customer bases uptilting the Hegele skill set and experience from around the globe.”

Alex Silva, MR In Site CEO and founder, adds “It was critical to us that our future partner shares the same dedication to quality and reliability as we do. At the end of the day, we are providing services that impact our surrounding community. We are glad to have found a partner in Simon Hegele Healthcare Solutions that aligns with our values and we are looking forward to a great partnership.”

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“Working closely with leading interventionists, we designed the latest Azurion neuro biplane to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment.  Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health," said Mark Stoffels, Business Leader of Image Guided Therapy Systems at Philips.
LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy